Facing patent cliffs and wider economic uncertainty, several large pharma companies are laying off employees. Now, looking broadly across the U.S., the job loss picture is even more grim. Amid a downsizing push in government workforces, the U.S. shed over 172,000 jobs in February — the highest recorded monthly total since 2009, Challenger, Gray & Christmas reported last week. The sharp rise in layoffs was driven by the dramatic cuts in the government sector, which erased 62,242 jobs during the month.

https://www.pharmavoice.com/news/pharma-layoff-biotech-job-cut-biogen-bms-crispr/741967/